Biofrontera- Warrants (27/10/2026) Other Current Liabilities

As of the most recent data (June 2026), BFRIW shows a other current liabilities of $4.7M. That compares with $15M in the prior-year period — down 68.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BFRIW's other current liabilities is now $4.7M (was $15M) — a 68.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biofrontera- Warrants (27/10/2026) is outperforming or lagging.

Tracking BFRIW's other current liabilities over time shows whether Biofrontera- Warrants (27/10/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $4.7M That compares with $15M in the prior-year period — down 68.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Biofrontera- Warrants (27/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $4.7M) with ownership activity and broader fundamentals.

Biofrontera- Warrants (27/10/2026)'s other current liabilities is $4.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.